SCHEMBL19845481

SCHEMBL19845481

c1ccc(-c2ccccc2-c2nc(-c3cccc(-n4c5ccccc5c5cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc54)c3)nc(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ PTGER4 P35408 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.35
▸ GRM5 P41594 1/20 0.34
▸ ABCG2 Q9UNQ0 2/20 0.33
▸ NPY5R Q15761 1/20 0.32
▸ TSPO P30536 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ MEN1 O00255 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ CTDSP1 Q9GZU7 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19845474 1.00 KDM4E (0.41) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL19845487 0.97 KDM4E (0.38) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL19845465 0.96 KDM4E (0.44) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL19845439 0.96 KDM4E (0.44) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL22672096 0.95 KDM4E (0.43) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL19845488 0.94 KDM4E (0.40) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL19845486 0.94 KDM4E (0.40) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL19845536 0.94 KDM4E (0.42) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL15197831 0.94 KDM4E (0.42) KDM4EL3MBTL1ATMPTGER4PDE10A
SCHEMBL16726733 0.94 KDM4E (0.44) KDM4EL3MBTL1ATMPTGER4ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 — — US disclosed
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037574-A1 COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, ETV6, LEF1 KDM4E 2538/4885L3MBTL1 3274/4885ATM 3035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback